Alumis (ALMS) Stock: Buy, Sell, or Hold?
ALMS - Alumis Inc. Common Stock
$9.18
-0.72 (-7.27%)
▼
5d:
-19.19%
30d:
-64.07%
90d:
-56.08%
WAIT
LOW Confidence
Analysis Updated: Sep 11, 2026 12:00 AM ET
Earnings: Aug 12, 2026
0d
Smart Money Accumulation
Options open interest is building while the stock consolidates - a pattern consistent with institutional accumulation. View Scanner →
Signal fired Aug 24, 2026 at $23.03 · last confirmed Sep 9, 2026
Strength: 7.5/10
Get Alerted When ALMS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: ALMS is down 19.2% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: ALMS is down 19.2% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: ALMS is currently trading at $9.18, which is considered oversold relative to its 30-day fair value range of $14.11 to $27.62.
Technical Outlook: Technically, ALMS is showing sideways momentum. Immediate support is located at $8.75, while resistance sits at $23.28. Short-term momentum is weak, with the stock down 7.3% recently.
Market Sentiment: The stock scores a mixed 55/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $32.12 (+249.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ALMS is showing sideways momentum. Immediate support is located at $8.75, while resistance sits at $23.28. Short-term momentum is weak, with the stock down 7.3% recently.
Market Sentiment: The stock scores a mixed 55/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $32.12 (+249.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$14.11 -
$27.62
Company Quality Score
53/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
72.1%
Protect Your Profits
Holding ALMS? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (55/100)
- BEARISH: Downward momentum (-7.3%)
- BULLISH: Trading 249.9% below Wall St target ($32.12)
- WARNING: Composite score 52/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$14.11 -
$27.62
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$8.75
Resistance Level
$23.28
Current Trend
Sideways
Technical data as of
Sep 11, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-3.19
Wall Street Target
$32.13
(+249.9%)
Revenue Growth (YoY)
-37.7%
Share & Embed Analysis
Last updated: September 12, 2026 7:50 AM ET
Data refreshes hourly during market hours. Next update: 8:50 AM
Data refreshes hourly during market hours. Next update: 8:50 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ALMS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$91 | 58 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$285 | 56 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$36 | 45 HOLD |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$34 | 60 BUY |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$109 | 57 HOLD |
Advanced ALMS Option Strategies
Professional options setups generated by AI based on today's ALMS price and gamma walls.
